glp-1 agonists and health coaching Agonists: Using Semaglutide, Tirzepatide, Orforglipron for Weight Loss and Obesity Health Coaching
Description
Overall risk of bias for the primary outcome was low in all studies
According to the World Health Organization, around 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to diabetes each year
This change means that GLP-1s can also alter the way birth control and other medications that are taken orally are absorbed
In fact, some people report mood changes on the drug
It shows that GLP-1 therapy is no longer only a weight loss conversation
